- Boris Fröhlich comes as new CEO from the B. Braun Melsungen AG
- Evelyn Thome takes on the position of CFO for Medical as well
Mannheim-based plastics expert Röchling restructures its Medical division: On 1 January 2020, Dr. Boris Fröhlich will take over the position of CEO in the Medical division from Prof. Hanns-Peter Knaebel, who will in the future be responsible for the Automotive and Medical divisions on the Group Executive Board in addition to his role as CEO of the Röchling Group. Boris Fröhlich will also be responsible for marketing and sales in Röchling’s smallest division as Chief Sales Officer.
He will be supported by Evelyn Thome, who will take on the role of CFO of Röchling Medical alongside her position as CFO of the Röchling Group. Knaebel will take over as Chairman of Röchling Medical’s Supervisory Board: “Boris Fröhlich and Evelyn Thome are an excellent choice for Röchling Medical’s Executive Board. I will continue to strongly support the Board in my new role,” he said.
Boris Fröhlich moved to Röchling from the pharmaceutical and medical technology company B. Braun Melsungen AG, where he was Managing Director of B. Braun Deutschland GmbH & Co. KG and Senior Vice President of Marketing and Sales Germany. He also worked as a project manager for the spin-off of B. Braun Deutschland GmbH & Co. KG.
The 51-year-old studied medicine in Heidelberg. Fröhlich then worked in the Salem hospital in Heidelberg and, from 2001 to 2008, in the hospital for general, gastro-intestinal and transplant surgery at the Heidelberg University Hospital. As well as being chief physician, he was also awarded his doctorate there in 2007.
In 2009, he joined the medical technology company Aesculap in Tuttlingen where Fröhlich worked in various roles until 2016, the last of which were that of Vice President of Global Marketing Indication Management Neuro and Cardiothoracic Surgery and Head of Marketing Expert Management. He switched to the Aesculap parent company B. Braun Melsungen AG in 2016. Boris Fröhlich graduated with a Master’s degree in business administration medical devices and healthcare management from Furtwangen University in 2013.
“Boris Fröhlich joined our team as an exceptionally experienced manager from the medical technology industry. I have known him personally for over 20 years and have worked with him for many years. His expertise, personality and creativity will help keep us on the path to success,” said Knaebel.
Following the restructuring of Röchling Medical, Knaebel will officially be appointed CEO of Röchling Automotive on 1 January 2020, a position that he has already held on a temporary basis for the last few months. “We have introduced many changes at Röchling Automotive in the last six months, which we have pooled in part in the structural project DRIVING FUTURE. It is important to me that we support this process with the Executive Board of Röchling Automotive SE,” said Knaebel.
Röchling SE & Co. KG